SGS Expands & Increases Capacity 50%


SGS, a leading bio/pharmaceutical analytical and bioanalytical contract solutions provider, is expanding its facility in Lincolnshire, in the northern suburbs of Chicago, IL. The expansion will increase the site’s current footprint from 38,500 square feet to nearly 58,000 square feet and is due to be completed by September 2017.

The expansion will allow the facility to increase capacity for the wide range of services that it offers, including analytical method development and testing, microbiological evaluation, drug stability studies, testing of containers and medical devices, and utilities qualification and monitoring. Additional staff will be employed to meet the demands on the laboratory.

“This investment allows us to be flexible in our approach to meeting both existing and future customer demands,” said James Nokes, Vice President, US Agriculture, Food, and Life. “Analysis and bioanalysis techniques continue to evolve rapidly and are driven by technological advances and regulatory needs. At SGS, it is our aim to ensure we can offer our clients integrated solutions to support their needs, so we continue to invest in capabilities, capacity, and our staff to maintain our professionalism and efficiency.”

The expansion at SGS’s Lincolnshire site follows a series of recent investments at the company’s global laboratory network. Increases in extractables and leachables capabilities have taken place at Fairfield, NJ, and Shanghai, China; while French facilities at Poitiers and Villeneuve-la-Garenne have seen investment in bioanalytical capabilities and elemental analysis, respectively.

With 20 laboratories offering contract analytical and bioanalytical services, SGS leverages its wholly owned global network, present in North America, Europe, and Asia, to deliver harmonized solutions to large pharmaceutical and biotechnology firms. In addition to testing services for the bio/pharmaceutical market, SGS also provides Phase I-IV clinical trial management, and services encompassing data management and statistics, PK/PD modeling and simulation, pharmacovigilance, and regulatory consultancy.

SGS is the world’s leading inspection, verification, testing, and certification company. SGS is recognized as the global benchmark for quality and integrity.
With more than 90,000 employees, SGS operates a network of over 2,000 offices and laboratories around the world.